Alessandra B.
- Country
- Italy
- Department
- Medical Oncology
Research Overview
- Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
- Phase Ib/II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT324 in Combination with BNT327 in Participants with Advanced Lung Cancer
- Phase 2 Study of ABBV-706 and Atezolizumab versus Standard of Care in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 372 of 633 partner sites.
Specializations
Advanced NSCLC Treatment
Specialized focus on treating advanced non-small cell lung cancer through various therapeutic approaches, including targeted therapies for specific genetic mutations like EGFR, HER2, and ROS1 alterations.
- Mutation-specific treatments
- Targeted therapeutic approaches
- Advanced stage management
Immunotherapy Research
Expertise in immunotherapy treatments for lung cancer, particularly investigating novel combinations with PD-1/PD-L1 inhibitors and evaluating immune response in different patient populations.
- Combination immunotherapy strategies
- Treatment resistance mechanisms
- Novel immunotherapy agents
Precision Medicine Applications
Focus on biomarker-driven therapies and personalized treatment approaches, particularly in cases involving MET alterations and other specific molecular targets in lung cancer.
- Molecular profiling
- Biomarker analysis
- Targeted therapeutic development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.